NPTX2 and Alzheimer disease: Several biomarker discovery studies using mass spectrometry methods have identified changes in CSF levels of NPTX2 or NPTX1 in AD [12,40,41] and decreased Neuronal Pentraxin Receptor in Frontotemporal Dementia [42].